Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Instil Bio Inc TIL

Healthcare Biotechnology
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a... see more

Recent & Breaking News (NDAQ:TIL)

Till Capital Receives $1,546,823 CDN From Sale of Golden Predator Mining Shares

GlobeNewswire June 8, 2016

Till Capital Reports 1st Quarter 2016 Operational and Financial Results

GlobeNewswire May 24, 2016

Till Capital Reports 2015 Operational and Financial Results

GlobeNewswire May 12, 2016

Till Capital Reports Brief Delay in Filing of Financials

GlobeNewswire April 29, 2016

Till Capital Announces Amendments of Promissory Notes

GlobeNewswire April 28, 2016

Till Capital Appoints Brian P. Lupien as CFO, and Weiying ("Mary") Zhu as Treasurer

GlobeNewswire March 17, 2016

Till Capital Announces Resignation of Chief Financial Officer

GlobeNewswire January 22, 2016

Till Capital Announces Appointment of Dr. Terry Rickard as Interim CEO

GlobeNewswire January 7, 2016

Till Capital Announces Amendment of Loan to Silver Predator

GlobeNewswire January 4, 2016

Till Capital Announces Auditor Change

GlobeNewswire December 23, 2015

Till Capital Receives $96,000 CDN From Sale of Golden Predator Mining Shares

GlobeNewswire November 11, 2015

Till Capital Announces Results of Annual and Special Meeting

GlobeNewswire October 19, 2015

Till Capital Announces Normal Course Issuer Bid

GlobeNewswire September 25, 2015

IIROC Trading Resumption - TIL

Canada NewsWire September 2, 2015

IIROC Trade Resumption - Till Capital Ltd.

Newsfile September 2, 2015

Till Capital Announces Board and Executive Changes

GlobeNewswire September 2, 2015

IIROC Trade Halt - Till Capital Ltd.

Newsfile September 2, 2015

IIROC Trading Halt - TIL

Canada NewsWire September 2, 2015

Till Capital Announces Loan to Silver Predator and Novation of Reinsurance Contracts

GlobeNewswire August 28, 2015

Till Capital Reports on Golden Predator Annual General Meeting

GlobeNewswire August 24, 2015